LMR Partners’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

LMR Partners’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,880	Closed	-$252K	–	1313
2022 Q4	$252K	Buy	+16,880	New	+$234K	﹤0.01%	975
2019 Q4	–	Sell	-6,660	Closed	-$56K	–	627
2019 Q3	$56K	Hold	6,660	–	–	﹤0.01%	374
2019 Q2	$45K	Buy	+6,660	New	+$57K	﹤0.01%	382
2014 Q4	–	Sell	-1,123	Closed	-$13K	–	504
2014 Q3	$13K	Sell	1,123 -10,108	-90%	-$128K	﹤0.01%	315
2014 Q2	$205K	Buy	+11,231	New	+$146K	0.02%	393

LMR Partners's AVEO Position: Q1 2023 in Review

LMR Partners sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 16,880 shares — an estimated $252K sold.

LMR Partners first reported a position in AVEO in Q2 2014 and held it in 5 quarters. The position peaked at $252K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

LMR Partners reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
LMR Partners sold 16,880 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $252K.
LMR Partners first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2014 and held it in 5 quarters.
LMR Partners's AVEO Pharmaceuticals, Inc. position peaked at $252K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on LMR Partners's 13F filing for Q1 2023, filed 15 May 2023.